Literature DB >> 31954528

Bacterial Inclusion Bodies: A Treasure Trove of Bioactive Proteins.

Priyank Singhvi1, Ankit Saneja1, Sudeepa Srichandan1, Amulya K Panda2.   

Abstract

Recombinant proteins expressed as bacterial inclusion bodies (IBs) are now receiving tremendous attention for many diverse applications in the areas of industrial and medical biotechnology. Understanding the structure-function relationship of protein in IBs has recently created new possibilities in developing innovative isolation, solubilization, refolding, and purification processes for high-throughput recovery of bioactive protein from bacterial IBs. This opinion article describes the advantages, disadvantages, and major challenges presently associated with each of the processing steps. Finally, we conclude with the possible solutions for each operational step and the future direction of the basic and translational research to achieve maximum benefit from IB aggregates.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Keywords:  bacterial inclusion bodies; combinatorial approach; mild solubilization agents; protein aggregates; protein purification; protein refolding

Mesh:

Substances:

Year:  2020        PMID: 31954528     DOI: 10.1016/j.tibtech.2019.12.011

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  17 in total

1.  Solubilization and Refolding of Inclusion Body Proteins.

Authors:  Priyank Singhvi; Amulya K Panda
Journal:  Methods Mol Biol       Date:  2022

2.  RBD decorated PLA nanoparticle admixture with aluminum hydroxide elicit robust and long lasting immune response against SARS-CoV-2.

Authors:  Jairam Meena; Priyank Singhvi; Sudeepa Srichandan; Jyotsna Dandotiya; Juhi Verma; Mamta Singh; Rahul Ahuja; Neha Panwar; Tabiya Qayoom Wani; Ritika Khatri; Gazala Siddiqui; Anuradha Gupta; Sweety Samal; Amulya Kumar Panda
Journal:  Eur J Pharm Biopharm       Date:  2022-05-17       Impact factor: 5.589

3.  Economic optimization of expression of soluble human epidermal growth factor in Escherichia coli.

Authors:  Kun Liu; Feng-Qing Wang; Ming Zhao; Bei Gao; Hong Xu; Dongzhi Wei
Journal:  Biotechnol Lett       Date:  2022-10-21       Impact factor: 2.716

4.  Exploring the use of leucine zippers for the generation of a new class of inclusion bodies for pharma and biotechnological applications.

Authors:  Ramon Roca-Pinilla; Sara Fortuna; Antonino Natalello; Alejandro Sánchez-Chardi; Diletta Ami; Anna Arís; Elena Garcia-Fruitós
Journal:  Microb Cell Fact       Date:  2020-09-04       Impact factor: 5.328

Review 5.  Challenges Associated With the Formation of Recombinant Protein Inclusion Bodies in Escherichia coli and Strategies to Address Them for Industrial Applications.

Authors:  Arshpreet Bhatwa; Weijun Wang; Yousef I Hassan; Nadine Abraham; Xiu-Zhen Li; Ting Zhou
Journal:  Front Bioeng Biotechnol       Date:  2021-02-10

Review 6.  Downstream processing of recombinant human insulin and its analogues production from E. coli inclusion bodies.

Authors:  Yin Yin Siew; Wei Zhang
Journal:  Bioresour Bioprocess       Date:  2021-07-27

7.  One-step heating strategy for efficient solubilization of recombinant spider silk protein from inclusion bodies.

Authors:  Hui Cai; Gefei Chen; Hairui Yu; Ying Tang; Sidong Xiong; Xingmei Qi
Journal:  BMC Biotechnol       Date:  2020-07-10       Impact factor: 2.563

8.  Recombinant Protein-Based Nanoparticles: Elucidating their Inflammatory Effects In Vivo and their Potential as a New Therapeutic Format.

Authors:  Laia Gifre-Renom; Estefania Ugarte-Berzal; Erik Martens; Lise Boon; Olivia Cano-Garrido; Esther Martínez-Núñez; Teresa Luque; Ramon Roca-Pinilla; Òscar Conchillo-Solé; Neus Ferrer-Miralles; Antonio Villaverde; Ghislain Opdenakker; Elena Garcia-Fruitós; Anna Arís
Journal:  Pharmaceutics       Date:  2020-05-13       Impact factor: 6.321

9.  Nucleic acids in inclusion bodies obtained from E. coli cells expressing human interferon-gamma.

Authors:  Elena Krachmarova; Ivan Ivanov; Genoveva Nacheva
Journal:  Microb Cell Fact       Date:  2020-07-11       Impact factor: 5.328

10.  Native to designed: microbial -amylases for industrial applications.

Authors:  Si Jie Lim; Siti Nurbaya Oslan
Journal:  PeerJ       Date:  2021-05-18       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.